brand · release 2026-09-20

XYMOGEN

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Formulations116

Conditional mean GIS65.91

Coverage10.3%

Axes 1–2 · Brand Index

Conditional score and coverage

Opacity share 0.9%. Brand results are not ordered when coverage bounds overlap. A brand-level sensitivity interval is undefined because the release preserves formulation-level intervals.

Axes 3–4

Measurement status and document panel

Not a measurement product, so this axis does not apply.

No brand review panel is published in this release.

Price column

Brand price aggregation

undefined: prices are retained at label-version level and are not averaged across formulations.

Brand profile

What this brand's labels look like as a set

Named strains: 24 distinct designations printed across the 11 published products of this brand, compared without regard to letter case: B420, BB-6, BI-26, BL-5, Bb-03, Bb-06, Bl-04, Bl-05, HN-19, HN001, HN019, LB-87 …
Potency basis: Potency is stated at manufacture. 21 · Potency is stated through expiry. 22 · The potency basis is not stated. 20 · counted across 63 organism rows on its labels, not across products
Printed CFU across its labels: 4,000,000 – 125,000,000,000; median 5,000,000,000. Measured on the 45 of 63 organism rows that print a per-organism figure; labels stating only a blend total are not in this range.
Forms: Capsule: 8 · Powder: 2 · Tablet or Pill: 1 · counted across the 11 of 11 products whose label states a form
Observed prices: 0 of 11 published products
Printed claims per label: 2 on average across the 11 of 11 products whose label carries a parsed claim block. A printed claim is not evidence and enters no axis.
Observed reformulations: 31 label change(s) with a printed CFU or potency-basis change, counted only between two snapshots whose ingredient rows were both parsed

Products

Published product pages of this brand

Product	Gut Index Score
XYMOGEN Lacidofil	63.37
XYMOGEN Max GI	73.00
XYMOGEN Probio Defense	84.03
XYMOGEN ProbioMax 350 DF	64.14
XYMOGEN ProbioMax Complete DF	62.73
XYMOGEN ProbioMax Daily DF	59.34
XYMOGEN ProbioMax DF	59.34
XYMOGEN ProbioMax Lean DF	65.47
XYMOGEN ProbioMax Oral Natural Mixed Berry Flavor	88.75
XYMOGEN ProbioMax Plus DF	55.50
XYMOGEN ProbioMax Sb DF	84.25

Organisms

What this brand actually puts on its labels

Across its published products, 44 distinct organisms or ingredients are printed. The most frequent, with the number of published products carrying each:

Organism or ingredient	Published products of this brand
Bifidobacterium animalis	6
Bifidobacterium longum	6
Bifidobacterium animalis subsp. lactis HN019	6
Lactiplantibacillus plantarum	5
Lactiplantibacillus plantarum Lp-115	5
Lactobacillus acidophilus	5
Lactobacillus acidophilus La-14	5
Bifidobacterium longum Bl-05	4
Lacticaseibacillus rhamnosus	4
Bifidobacterium lactis	3
Saccharomyces boulardii	3
Bifidobacterium animalis subsp. lactis Bl-04	2
Bifidobacterium bifidum	2
Bifidobacterium breve	2

Elsewhere in this release

Findings computed over the whole corpus: Potency basis census · Supplier code network · Label designation changes

Tools: DSLD product check

Citation

Cite this page

Ivitskiy, I. (2026). XYMOGEN. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/b/xymogen/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

XYMOGEN has 102 eligible SKUs and 116 formulation groups among labels in the NIH DSLD snapshot (Sep 2026).
102 / 116 formulation groups · NIH DSLD snapshot Sep 2026 · brand.skus · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
14 of 116 XYMOGEN formulation groups have at least one printed strain designation (12.1%) in the NIH DSLD snapshot Sep 2026.
14 / 116 formulation groups · NIH DSLD snapshot Sep 2026 · brand.naming · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
1 of 116 XYMOGEN formulation groups were scored using the available matching evidence (0.9%) in the NIH DSLD snapshot Sep 2026.
1 / 116 formulation groups · NIH DSLD snapshot Sep 2026 · brand.opacity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
XYMOGEN: conditional Brand Index 65.91 from 12 of 116 formulation groups with numeric Gut Index Scores (10.3%); unscored groups remain outside the mean. Window: NIH DSLD snapshot Sep 2026.
12 / 116 formulation groups · NIH DSLD snapshot Sep 2026 · brand.index · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub